Low dose of insulin for assessment of growth hormone and cortisol release in short children

J Pediatr Endocrinol Metab. 2005 Aug;18(8):815-8. doi: 10.1515/jpem.2005.18.8.815.

Abstract

Objective: In 55 prepubertal children with growth failure, aged 8.62 +/- 2.89 years, we evaluated the efficacy of a test using only half the usual dose of insulin by comparing the results with those obtained during a classical arginine tolerance test, performed separately.

Patients and methods: The patients were randomly divided into two groups: group A consisting of 37 children received 0.05 U/kg insulin, while group B consisting of 18 patients received 0.1 U/kg insulin. Each child received the same dose of arginine per kg during the second test.

Results: Serum growth hormone (GH) peak levels were significantly (p < 0.01) lower in children of group A (6.59 +/- 4.10 ng/ml) than in those of group B (10.12 +/- 5.80 ng/ml). No differences of GH peak levels were found in patients of the two groups after arginine infusion. The injection of 0.05 U/kg insulin induced a significantly (p < 0.0001) lower percent decrease of serum glucose than 0.1 U/kg. No difference of the percent increase of serum cortisol induced by insulin at 0.05 U/kg and 0.1 U/kg was observed.

Conclusion: The diagnosis of GH deficiency in children can be supported by a blunted GH response after two or more pharmacological stimuli including hypoglycaemia induced by only half the usual dose of insulin.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Arginine
  • Child
  • Female
  • Growth Disorders / diagnosis*
  • Human Growth Hormone / deficiency*
  • Humans
  • Hydrocortisone / blood
  • Hydrocortisone / metabolism
  • Hypoglycemia
  • Hypoglycemic Agents* / administration & dosage
  • Insulin* / administration & dosage
  • Male
  • Sensitivity and Specificity

Substances

  • Hypoglycemic Agents
  • Insulin
  • Human Growth Hormone
  • Arginine
  • Hydrocortisone